Vigonvita Life Sciences Co., Ltd. (02630) published its monthly return as of 30 November 2025. The company’s total authorized share capital remained at RMB167,597,800, comprising 66,677,133 H shares and 100,920,667 unlisted shares, each with a par value of RMB1 and unchanged from the previous month.

The total number of issued shares stayed at 66,677,133 H shares and 100,920,667 unlisted shares, with no treasury shares reported. The H shares were newly listed on the Main Board of The Stock Exchange of Hong Kong Limited on 6 November 2025. There were no share options, warrants, or convertibles in issue during this period.